SBIR/STTR Research Award

SIMBIOSYS PHENOSCOPE: A CLOUD-ENABLED, WEB-BASED PORTAL FOR RAW AND PROCESSED CANCER PHENOTYPE DATA SPANNING SCALES FROM GENOMES TO TISSUES

Award identifier 6bb141b0eff51dfc2fdcd8fdd0e9b2602029b375cbe0acb4474bd32aa7650047Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$400,000

Program and phase

SBIR · Phase I

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SimBioSys, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
SFJ4KVWCA9N9
Solicitation number
Not reported
Topic code
408

Research abstract

While genomic methods yield a plethora of information on the underlying cause and variety of cancers, genotype is only one factor contributing to the observed phenotype of a tumor. Heterogeneity among cancers and differences within individual tumors continue to challenge the efforts to develop effective therapies. A multitude of data such as single cell sequencing, digital pathology, and medical imaging are being generated that captures heterogeneity across multiple scales. However, data is siloed and connections between scales remains elusive. We propose the development of SimBioSys PhenoScope, a novel research tool to harmonize these disparate data types and provide connections between the genomic, cellular/pathway, microscopic tissue environment, and tissue scales. Combining state-of-the art machine learning, dimensionality reduction techniques, novel spatio-temporal simulation algorithms, and support for public data repositories, PhenoScope will provide a new means of assessing factors contributing to a cancer's phenotypical behavior. As an exploratory data platform, the tool will provide novel multi-scale visualizations by relying on the novel analyses between scales, that could be used by academic and pharmaceutical researchers alike to generate hypotheses for new drug targets, dosing regimens, and research targets. This technology enables researchers and clinicians to study cancer in a new light, and lead the way in to the upcoming phenomics era.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

3 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $2,611,535. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.